获取途径

作者

陶 昊 种南南 董 琳

作者单位

山东第一医科大学(山东省医学科学院)研究生学院，山东 济南 山东第一医科大学第一附属医院血液科，山东 济南

刊名

Advances in Clinical Medicine

年份

2024

卷号

Vol.14 No.3

页码

1536-1543

ISSN

2161-8712

关键词

供者淋巴细胞输注 阿扎胞苷 造血干细胞移植 复发 Donor Lymphocyte Infusion Azacitidine Hematopoietic Stem Cell Transplantation Recurrence

摘要

Donor lymphocyte infusion is one of the effective strategies for the treatment of relapsed patients after allogeneic hematopoietic stem cell transplantation by inducing graft-versus-leukemia . This article reported a 14-year-old patient with hematological relapse after CMML transplantation. He received CAG regimen chemotherapy combined with granulocyte colony-stimulating factor mobilization modified donor lymphocyte infusion treatment, and maintenance treatment with azacitidine after MRD n...更多

Donor lymphocyte infusion is one of the effective strategies for the treatment of relapsed patients after allogeneic hematopoietic stem cell transplantation by inducing graft-versus-leukemia . This article reported a 14-year-old patient with hematological relapse after CMML transplantation. He received CAG regimen chemotherapy combined with granulocyte colony-stimulating factor mobilization modified donor lymphocyte infusion treatment, and maintenance treatment with azacitidine after MRD negative conversion achieved long-term remission.收起

文献类型

期刊